Related Articles
Gleditsia sinensis fruit extract is a potential chemotherapeutic agent in chronic and acute myelogenous leukemia
MicroRNA‑181a enhances the chemotherapeutic sensitivity of chronic myeloid leukemia to imatinib
Low‑dose radiation‑induced apoptosis in human leukemia K562 cells through mitochondrial pathways
Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia
HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway